Sequence Similarity Clusters for the Entities in PDB 1I8K

Entity #1 | Chains: A
EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV LIGHT CHAIN protein, length: 107 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 2 37190
95 % 1 2 31686 Flexibility: Low
Max RMSD: 0.8, Avg RMSD: 0.8
PDBFlex
90 % 1 2 30334
70 % 1 2 27156
50 % 46 331 19
40 % 52 375 27
30 % 728 7514 1
Entity #2 | Chains: B
EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV HEAVY CHAIN protein, length: 124 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 2 37189
95 % 1 2 31685 Flexibility: No
Max RMSD: 0.3, Avg RMSD: 0.3
PDBFlex
90 % 1 2 30333
70 % 90 431 9
50 % 112 646 6
40 % 600 6051 1
30 % 729 7514 1
Entity #3 | Chains: C
EPIDERMAL GROWTH FACTOR RECEPTOR, EGFRVIII PEPTIDE ANTIGEN protein, length: 12 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 5IVN 1 A BC2-nanobody 30538
2 5E7B 1 A nanobody nano-L06 9838
3 2P45 2 B ANTIBODY CAB-RN05 9838
4 2X1Q 1 A, B GELSOLIN NANOBODY 9844
5 5U64 1 B VHH-28 9838
6 6APO 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
7 2X1P 1 A, B, C, D GELSOLIN NANOBODY 9844
8 4B41 1 A, B ANTIBODY G7 9844
9 5IMM 1 B Nanobody 9835
10 4QYO 1 A Fv fragment(mAb6D8) heavy chain 10090
11 5NLU 1 A single domain llama antibody Nb36 9844
12 1MQK 2 H antibody 7E2 FV fragment, heavy chain 10090
13 5IMK 1 B Nanobody 9835
14 3TPK 1 A Immunoglobulin heavy chain antibody variable domain KW1 9835
15 4B50 1 A 2H10 LLAMA VHH 9844
16 6DBA 1 A, B nanobody VHH R303 9838
17 2XT1 2 B CAMELID VHH 9 30538
18 4QY8 1 A Fv fragment(mAb6D8) heavy chain 10090
19 5VLV 1 A Single Domain Camelid Nanobody VHH T9 9844
20 5J1S 3 C VHH domain BS-2 30538
21 2P49 2 B ANTIBODY CAB-RN05 TRUNCATED AT RESIDUE 121 9838
22 5J1T 3 C VHH domain BS-2 30538
23 5M13 2 B synthetic Nanobody L2_C06 (a-MBP#2) 32630
24 2X1O 1 A, B GELSOLIN NANOBODY 9844
25 4QGY 1 A, B nanobody n25, VH domain 9844
26 5C2B 1 H scFv 3B4 heavy chain 9606
27 5VNV 1 A Nb.b201 32630
28 5DXW 1 A PD-L1 nanobody 10090
29 4N9O 2 B Nanobody Nb484 Nb484 9844
30 4M3K 2 B Camelid heavy-chain antibody variable fragment cAb-H7S 9844
31 1OAQ 1 H HEAVY CHAIN FV, RESIDUES 1-121 10090
32 1T2J 1 A M12-Variable Heavy domain 9606
33 1DLF 2 H ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) FV FRAGMENT (VH AND VL DOMAINS) 10090
34 6DBF 2 B InlB specific VHH R303 9838
35 6DBG 2 C, D VHH R303 9838
36 2XA3 1 A LLAMA HEAVY CHAIN ANTIBODY D7 VARIABLE DOMAIN OF A HEAVY CHAIN ANTIBODY 9844
37 5VM6 1 A single domain camelid nanobody VHH T10 9844
38 1RJC 1 A camelid heavy chain antibody VHH DOMAIN, VARIABLE DOMAIN 9838
39 4KML 2 B Nanobody 9844
40 4Z9K 2 B VHH2(F5) antibody 30538
41 1J05 2 B, H anti-CEA mAb T84.66, heavy chain Fv fragment 10090
42 5LMW 1 A Nanobody 9844
43 5NM0 1 A, B, C, D Nb36 9844
44 4QXT 1 A Fv fragment(mAb6D8) heavy chain 10090
45 4WEM 2 B Anti-F4+ETEC bacteria VHH variable region 9844
46 4PPT 1 A Engineered single domain VHH antibody 9844
47 3R0M 1 A, B Llama VHH A12 9844
48 3ZKQ 2 D XA4813 9844
49 4I13 2 B Protein ca1697 (nanobody) 9844
50 5C2U 1 B Nanobody Nanobody 9838
51 1XFP 1 A heavy chain antibody VHH domain 9838
52 4POY 1 A VHH-metal 9844
53 1A2Y 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
54 5M2W 1 A, B Llama nanobody nb8 against TssK from T6SS 9844
55 5NLW 1 A nanobody Nb36 9844
56 2DLF 2 H PROTEIN (ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) (HEAVY CHAIN)) FV FRAGMENT (VH DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT 10090
57 1ZVH 2 A Immunoglobulin heavy chain antibody variable domain D2-L24 9838
58 2X6M 1 A HEAVY CHAIN VARIABLE DOMAIN FROM DROMEDARY ENGINEERED FROM IMMUNISED DROMEDARY 9838
59 3G9A 2 B Minimizer 9838
60 2P43 2 B ANTIBODY CAB-RN05 9838
61 4KRN 1 A Nanobody/VHH domain EgA1 9844
62 4GFT 2 B Nanobody 9844
63 4TVS 2 a, b VHH Domain BS-1 30538
64 4W6Y 2 B Nanobody NbFedF9 9844
65 6EZW 1 B VHH antibody BCD090-M2 9844
66 1UAC 2 H Ig VH,anti-lysozyme 10090
67 4HEM 2 E, F, G Anti-baseplate TP901-1 Llama vHH 02 9844
68 4R3S 1 A FV FRAGMENT(MAB6D8) HEAVY CHAIN 10090
69 5M14 2 C, D synthetic Nanobody L2_G11 (a-MBP#2) 32630
70 1YC7 1 A, B anti-VSG immunoglobulin heavy chain variable domain cAbAn33 cAbAn33 9838
71 5O02 2 C Nanobody (VHH) Nano-4 30538
72 1KXQ 2 E, F, G, H antibody VHH fragment CABAMD9 9838
73 4X7F 2 C, D Nano-25 Nanobody 30538
74 4UT7 1 H BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 SCFV HEAVY CHAIN DOMAIN, RESIDUES 1-130 9606
75 4LGR 2 B Camelid nanobody (VHH3) 30538
76 5J57 2 B VHH single chain antibody V5E1 30538
77 6BA5 2 B, D, F, H Variable domain Heavy chain, antibody R11 9606
78 1MFA 2 H IGG1-LAMBDA SE155-4 FAB (HEAVY CHAIN) 10090
79 5OMM 2 C Nanobody (VHH) Nano-14 30538
80 5E03 1 A mouse CTLA-4 nanobody 10090
81 5LZ0 1 A, B PorM nanobody 9844
82 1KXV 2 C, D CAMELID VHH DOMAIN CAB10 9838
83 6DBE 1 A, B nanobody VHH R303 9844
84 2XXC 1 B CAMELID VHH 9 30538
85 3QYC 1 A, B VH domain of IgG molecule 9606
86 5VAK 2 B Nb914 Nanobody 9844
87 2XXM 2 B CAMELID VHH 9 30538
88 3QXT 1 A, B Anti-Methotrexate CDR1-3 Graft VHH 9844
89 6DBD 1 A, B, C, D nanobody VHH R326 9844
90 5JDS 1 B Nanobody 9835
91 4OB5 1 H 4E10 antibody germline precursor 7 heavy chain Fv 9606
92 1ZVY 1 A Immunoglobulin heavy chain antibody variable domain D3-L11 9838
93 1U0Q 1 A, B immunoglobulin heavy chain variable domain 9844
94 5L21 2 B VHH-C2 30538
95 5FWO 1 A NANOBODY 9844
96 5KVE 3 H ZV-48 Antibody scFv Heavy chain 10090
97 1OL0 1 A, B IMMUNOGLOBULIN G VARIABLE HEAVY DOMAIN 9606
98 3B9V 1 A, B, C, D heavy chain variable domain 9606
99 4W2P 1 A, B, C, D Anti-Marburgvirus Nucleoprotein Single Domain Antibody C 9844
100 1VFA 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
101 5N88 1 A, H VH59 antibody 9606
102 2D7T 1 H anti polyhydroxybutyrate antibody Fv, heavy chain residues 1-133 9606
103 2OTU 2 B, D, F, H Fv heavy chain variable domain 10090
104 6APP 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
105 2E27 2 H anti-ciguatoxin antibody, heavy chain Fv fragment 10090
106 4POU 2 B VHH Antibody 9844
107 1MVF 1 A, B immunoglobulin heavy chain variable region 9838
108 4JVP 1 A, B Anti-HCV E2 alpaca nanobody D03 30538
109 3QSK 2 B Engineered 5 Histidine anti-RNase A Camelid VHH Antibody Domain Variant 9838
110 4EJ1 2 C, D Nb113 camelid antibody fragment 9844
111 2P42 2 B, D ANTIBODY CAB-RN05 9838
112 1I8K 2 B EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV HEAVY CHAIN 10090
113 4QLR 1 A, B Llama nanobody n02 VH domain 9844
114 5J56 2 B VHH single chain antibody V1C7 30538
115 4NBX 2 B A20.1 VHH 9844
116 1G7J 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
117 4HEP 2 G vHH17 domain 9844
118 3QXU 1 A, B, C, D Anti-Methotrexate CDR1-3 Graft 9844
119 1VFB 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
120 5IML 2 B Nanobody 9835
121 3A6C 2 H IG VH, anti-lysozyme 10090
122 2DQD 2 H Ig VH,anti-lysozyme 10090
123 1HCV 1 A IMMUNOGLOBULIN G FROM IMMUNIZED LLAMA HEAVY CHAIN VARIABLE DOMAIN FROM LLAMA 9844
124 1G7I 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
125 3A67 2 H IG VH, anti-lysozyme 10090
126 1RI8 1 A camelid ANTIBODY HEAVY CHAIN VHH domain, VARIABLE DOMAIN 9838
127 1J1X 2 H Ig VH,anti-lysozyme 10090
128 5M2J 2 D Anti-(ED-B) scFV 9606
129 2DQC 2 H Ig VH,anti-lysozyme 10090
130 1J1O 2 H Ig VH,anti-lysozyme 10090
131 1MVU 2 B Ig VDJ-region (HEAVY CHAIN) LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER 10090
132 4M62 2 H, I GEP2 FV heavy chain 9606
133 5IVO 1 A BC2-nanobody 30538
134 1J1P 2 H Ig VH,anti-lysozyme 10090
135 4NBZ 2 B, D A26.8 VHH 9844
136 5AYU 2 H Ig VH,anti-lysozyme 10090
137 3A6B 2 H IG VH, anti-lysozyme 10090
138 2DQJ 2 H Ig VH,anti-lysozyme 10090
139 5F21 2 B nanobody MU375 9844
140 1N4X 2 H, I immunoglobulin heavy chain variable region 10090
141 2P44 2 B ANTIBODY CAB-RN05 9838
142 1KIQ 2 B MONOCLONAL ANTIBODY D1.3 10090
143 5TP3 1 A, B F-VHH-4 9844
144 5E0Q 1 A Anti-Nup98 Nanobody TP377 30538
145 4LHJ 2 B Camelid antibody 30538
146 4BEL 2 D, E XA4813 9844
147 5M7Q 1 A, B Nanobody NbD2 9838
148 5H8D 1 A VHH nanobody 9844
149 3LN9 1 A Immunoglobulin heavy chain antibody variable domain B10 9835
150 5IP4 1 A, B XA4551 NANOBODY AGAINST C-DCX 9844
151 3DUR 2 B, D Ig-like protein 10090
152 2XV6 2 B, D CAMELID VHH 9 30538
153 4QO1 1 A Nb139 Nanobody against the DNA-binding domain of p53 9844
154 5VM0 1 A, B Camelid Nanobody VHH T9 9844
155 4ZG1 1 A, B, C, D, E, F NB17 9844
156 6BAN 2 B, D, F, H Variable domain R11 Heavy chain 9606
157 4I1N 2 B Protein ca1697 (nanobody) 9844
158 3QXW 1 A, B, C, D, E Anti-Methotrexate CDR1-4 Graft VHH 9844
159 6F0D 1 A, B VHH antibody BCD090-M2 9844
160 1FGV 2 H H52 FV (HEAVY CHAIN) 9606
161 4LCI 2 H anti canine CD28 antibody, 1C6, heavy chain 10090
162 4W6X 2 B Nanobody NbFedF7 9844
163 5JA9 2 A, B Nanobody 6 9844
164 1A7N 2 H IGG1-KAPPA D1.3 FV (HEAVY CHAIN) FV FRAGMENT 10090
165 1JTP 1 A, B Single-Domain Antibody VH DOMAIN FRAGMENT 9838
166 1OP9 1 A HL6 camel VHH fragment 9838
167 2P4A 2 B, D ANTIBODY CAB-RN05 TRUNCATED AT RESIDUE 121 9838
168 4LRN 1 H GEP 1 heavy chain 9606
169 4S11 1 A GELSOLIN NANOBODY 9844
170 4WEN 2 B Anti-F4+ETEC bacteria VHH variable region 9844
171 2YC1 1 A, D SINGLE CHAIN ANTIBODY FRAGMENT 9004G HEAVY CHAIN 9606
172 5HGG 2 S, T Camelid Derived Antibody Fragment, Nb4 30538
173 6APQ 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody B 9844
174 1SHM 1 A, B, D, E ANTIBODY RIG RIG VHH 9844
175 1G7H 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
176 4Y7M 1 A, B Hi113 protein 9844
177 5JMO 2 C, D camelid VHH fragment 9838
178 1A7O 2 H IGG1-KAPPA D1.3 FV (HEAVY CHAIN) FV FRAGMENT 10090
179 1KIR 2 B MONOCLONAL ANTIBODY D1.3 10090
180 4B5E 1 A, B PS2-8 9844
181 2DQE 2 H Ig VH,anti-lysozyme 10090
182 1DVF 2 B FV D1.3 IGG1, KAPPA 10090
183 1DVF 4 D FV E5.2 IGG1, KAPPA 10090
184 1G7M 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
185 4X7C 2 C, D Nano-85 Nanobody VHH 30538
186 1OAU 1 H, I, J, K IMMUNOGLOBULIN E FV REGION, RESIDUES 1-122 10090
187 3EBA 1 A CAbHul6 9838
188 3ZHD 1 A, B MG8-4 SCAFFOLD ANTIBODY HUMAN HEAVY CHAIN DOMAIN 9606
189 1A6W 2 H B1-8 FV (HEAVY CHAIN) FV FRAGMENT 10090
190 1A7R 2 H IGG1-KAPPA D1.3 FV (HEAVY CHAIN) FV FRAGMENT 10090
191 5VM4 1 A, B, C, D, E, F, G, H, I, J, K, L Single domain camelid nanobody VHH T10 9844
192 1WZ1 2 H Ig heavy chain Fv fragment(residues 1-123) 10090
193 4I0C 2 C, D cAbHuL5 antibody 9838
194 1A7P 2 H IGG1-KAPPA D1.3 FV (HEAVY CHAIN) FV FRAGMENT 10090
195 1XIW 4 D, H immunoglobulin heavy chain variable region 10090
196 5NGV 2 H anti-human ActRIIB mAb BYM338 heavy-chain C-terminal His6-tag VH 9606
197 1A7Q 2 H IGG1-KAPPA D1.3 FV (HEAVY CHAIN) FV FRAGMENT 10090
198 5BOP 1 A, C Nanobody 9844
199 4DKA 1 A, B single domain antibody VHH 9844
200 5O05 1 C, D Nanobody (VHH) Nano-42 30538
201 1OHQ 1 A, B IMMUNOGLOBULIN FV FRAGMENT, RESIDUES 1-120 9606
202 1DSF 2 H ANTICANCER ANTIBODY B1 FV 10090
203 3DUU 2 B, D Ig-like protein 10090
204 3K74 2 B Nanobody 9844
205 5M15 2 C, D Synthetic nanobody L2_D09, (a-MBP#3) 32630
206 1KIP 2 B MONOCLONAL ANTIBODY D1.3 10090
207 6A3W 1 A, D, G, J utomilumab VH 9606
208 2EIZ 2 B ANTI-LYSOZYME ANTIBODY FV REGION VH FRAGMENT 9606
209 1SJV 1 A r9 llama VHH single domain antibody 9844
210 4M3J 1 A, B Camelid heavy-chain antibody variable fragment cAb-H7S 9844
211 5VL2 1 A, B, C, D, E, F, G, H T4 nanobody 9844
212 6GZP 1 A Nanobody 9844
213 2UZI 1 H ANTI-RAS FV HEAVY CHAIN 9606
214 1UA6 2 H Ig VH,anti-lysozyme 10090
215 1IC7 2 H IGG1 FAB CHAIN H RESIDUES 1-114 10090
216 4W68 1 A, B Single domain antibody 9844
217 1JTT 1 A Vh Single-Domain Antibody VH domain fragment 9838
218 1CFV 2 H MONOCLONAL ANTIBODY FV4155 FV FRAGMENT 10090
219 3EAK 1 A, B NbBCII10-FGLA 9838
220 1KXT 2 B, D, F IMMUNOGLOBULIN VHH FRAGMENT 9838
221 4ORZ 3 C single domain antibody sdAb19 9844
222 4UU9 1 A, H MEDI7814 VARIABLE DOMAIN HEAVY CHAIN 9606
223 6EY6 2 I, J, K, L, M, N, O, P nb130 9844
224 2VYR 2 E, F, G, H, I, J, K, L HUMAN SINGLE DOMAIN ANTIBODY 9606
225 1G7L 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
226 1BFV 2 H FV4155 MONOCLONAL ANTIBODY FV FRAGMENT 10090
227 5C1M 2 B Nanobody 39 9844
228 5F7K 2 C, D Nanobody Nb-ER19 9844
229 5LMJ 1 A, B, C, D nanobody 9844
230 5E1H 2 B F8(JOB10) VHH antibody 30538
231 1F2X 1 K, L ANTIBODY HEAVY CHAIN 9838
232 4OCM 3 C, F Nb1 9844
233 5HDO 1 A, B, C, D Anti-HCV NS3/4A serine protease immoglobulin heavy chain 9838
234 1A6U 2 H B1-8 FV (HEAVY CHAIN) FV FRAGMENT 10090
235 4X7E 2 C, D Nano-85 Nanobody 30538
236 5F1O 2 B nanobody MU551 9844
237 1ZV5 2 A immunoglobulin heavy chain antibody variable domain VHH D2-L29 9838
238 5O03 2 C, D Nanobody (VHH) Nano-32 9844
239 2DQI 2 H Ig VH,anti-lysozyme 10090
240 4Y8D 2 C, D nanobody 9844
241 3CX5 10 J, U HEAVY CHAIN (VH) OF FV-FRAGMENT 10090
242 4EIZ 2 C, D Nb113 Camel antibody fragment 9844
243 1I3U 1 A ANTIBODY VHH LAMA DOMAIN 9844
244 1I3V 1 A, B ANTIBODY VHH LAMA DOMAIN 9844
245 4C58 2 B NANOBODY 9844
246 5B8C 2 B, E, H, K Pembrolizumab heavy chain variable region (PemVH) 9606
247 3DV6 2 B Ig-like protein 10090
248 4LAJ 3 H, I, L, M Llama single domain antibody, JM4 9844
249 2EKS 2 B ANTI-LYSOZYME ANTIBODY FV REGION VH FRAGMENT 9606
250 5VXM 2 B Single-domain antibody 20ipaD 30538
251 4XVJ 2 H antibody heavy chain variable domain 9606
252 4IDL 1 A Single Domain Antibody VHH A9 9844
253 1JV5 2 B Ig chain heavy chain precursor V region 9606
254 1FVC 2 B, D IGG1-KAPPA 4D5 FV (HEAVY CHAIN) 9606
255 3K7U 1 A Antibody 9844
256 4Z0X 2 B Antibody HC26AM heavy chain variable domain 9606
257 1IC5 2 H IGG1 FAB CHAIN H RESIDUES 1-114 10090
258 4NBY 2 B, C A20.1 VHH 9844
259 4X7D 2 C, D Nano-85 Nanobody VHH 9844
260 5VAN 2 B Nb914 Nanobody 9844
261 5F7N 2 C, D Nanobody Nb-ER19 30538
262 5OCL 1 A, C, F, H anti-llama nanobody 30538
263 5OCL 2 B, D, E, G anti-vglut nanobody 9844
264 4LAS 1 H Single heavy chain Variable fragment Heavy chain 10090
265 2A9M 2 H, I fluorescein-scfv heavy chain 9606
266 5E5M 2 B, D, F, H mouse anti CTLA-4 nanobody 10090
267 1SJX 1 A immunoglobulin VH domain 9844
268 3ZKS 2 D XA4813 9844
269 1A6V 2 H, I, J B1-8 FV (HEAVY CHAIN) FV FRAGMENT 10090
270 5MY6 2 B Nanobody 2Rs15d 9838
271 3DUS 2 B, D Ig-like protein 10090
272 5NH3 2 H, I anti-human ActRIIB mAb BYM338 Fv heavy-chain 9606
273 5M2I 2 G, H, I, J, K, L VHH1 9844
274 5MWN 2 D, E, F llama nanobody raised against TssK, nbK18 9844
275 5MWN 3 N llama nanobody raised against TssK, nbK27 9844
276 3ZHK 1 A, B MG2X1 SCAFFOLD ANTIBODY 9606
277 3K1K 2 C, D Enhancer 9838
278 4U7S 1 A, B sdAb A3 9844
279 4U3X 1 A, C Human VH domain antibody 9606
280 4W81 1 A Single Domain Antibody 9844
281 5GRV 1 L homo-specific diabody heavy chain 9606
282 5JMR 1 A, B camelid VHH fragment 9838
283 4W70 1 A Single Domain Antibody 9844
284 2GSG 2 B, D monoclonal antibody heavy chain variable domain 10090
285 5TBD 1 A, D, E, J Fv fragment (mAb4D1) heavy chain 10090
286 4BFB 2 D, E XA4813 9844
287 5DHV 1 A Anti-Rev Antibody Fab single-chain variable fragment, heavy chain 9986
288 5DHV 3 H Anti-Rev Antibody Fab single-chain variable fragment, heavy chain 9986
289 43C9 2 B, D, F, H PROTEIN (IMMUNOGLOBULIN (HEAVY CHAIN)) FV 10090
290 1NMB 3 H FAB NC10 RESOLUTION OF 2.5 ANGSTROMS 10090
291 5LHR 2 B Camelid-Derived Antibody Fragment Nb22 30538
292 1I8I 2 B EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV HEAVY CHAIN 10090
293 1OAR 1 H, I, J, K IMMUNOGLOBULIN E FV, RESIDUES 1-122 10090
294 4LHQ 2 B, D Camelid nanobody 30538
295 3DV4 2 B Ig-like protein 10090
296 3ZKX 2 B XA4813 9844
297 3ZKX 3 C XA4815 9844
298 5F1K 2 C, D nanobody MU1053 9844
299 3ZLQ 2 C, D XA4813 9844
300 1I3G 2 H ANTIBODY FV FRAGMENT VH DOMAIN 10090
301 1DL7 2 H PROTEIN (ANTIBODY M3C65 (HEAVY CHAIN)) FV (SINGLE CHAIN) 10090
302 4NC0 2 B A26.8 VHH 9844
303 1OCW 1 H IMMUNOGLOBULIN E FV REGION, RESIDUES 1-121 10090
304 1IGM 2 H IGM-KAPPA POT FV (HEAVY CHAIN) 9606
305 5GS1 2 B, N, P, R heavy chain 9606
306 5F7Y 3 C, D Nanobody Nb-ER19 9844
307 2DQG 2 H Ig VH,anti-lysozyme 10090
308 5IMO 1 B Nanobody 9835
309 5U65 1 A, B VHH-5 9838
310 4TYU 1 A, B Single Domain Antibody 9844
311 43CA 2 B, D, F, H PROTEIN (IMMUNOGLOBULIN (HEAVY CHAIN)) FV 10090
312 2DQH 2 H Ig VH,anti-lysozyme 10090
313 4AQ1 2 B, D NBKB6 VHH 9844
314 6FV0 2 F nanobody 9844
315 4EIG 2 B CA1698 camel antibody fragment 9844
316 3EHB 3 C FV fragment Chain H 10090
317 6B20 3 E, F Nanobody against G protein beta gamma dimer 9844
318 3HB3 3 C ANTIBODY FV FRAGMENT 10090
319 4FFY 2 H DENV1-E111 single chain variable fragment (heavy chain) 10090
320 2X89 1 A, B, C ANTIBODY 9838
321 5M2M 2 D, E, F, H, J, N Llama nanobody VHH3 9844
322 5O04 2 E, F Nanobody (VHH) Nano-26 30538
323 5O04 3 C, D Nanobody (VHH) Nano-85 30538
324 5LBS 2 H, I BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C8 ScFv fragment, heavy chain 9606
325 3P9W 2 B, D, F, H human VEGF 9606
326 1AP2 2 B, D MONOCLONAL ANTIBODY C219 LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER FV 10090
327 5F8R 2 C, D Nanobody Nb-ER19 9844
328 1IC4 2 H IGG1 FAB CHAIN H RESIDUES 1-114 10090
329 4OCL 3 C, F Nb1 9844
330 4RAV 2 A, C single-chain Fv, VH 9606
331 5XJ4 2 H durvalumab-VH 9606
332 5LWY 2 H V REGION HEAVY CHAIN 10090
333 1KB9 10 J HEAVY CHAIN (VH) OF FV-FRAGMENT 10090
334 4X4X 1 A, C Human Variable Heavy Chain of Herceptin 9606
335 4IOS 2 D, E, F, G Llama nanobody 11 9844
336 5LHN 2 B Camelid-Derived Antibody Fragment Nb7 30538
337 2BFV 2 H FV4155 MONOCLONAL ANTIBODY FV FRAGMENT 10090
338 2IBZ 10 X Variable Heavy chain of antibody fragment 10090
339 4C57 2 C, D NANOBODY 9844
340 3ZHL 1 A MG8-14 SCAFFOLD ANTIBODY 9606
341 4OCN 3 C, F Nb1 9844
342 4GRW 3 E, G Nanobody 124C4 9844
343 4GRW 4 F, J Nanobody 37D5 9844
344 4GRW 5 H, I Nanobody 22E11 9844
345 5G5R 2 B NANOBODY NB330 SELECTED FROM LLAMA GLAMA 9844
346 4NC2 2 B B39 VHH 9844
347 2WZP 2 D, E, F, J, K, L CAMELID VHH5 9844
348 5LHQ 2 B Camelid-Derived Antibody Fragment Nb7 30538
349 1WT5 1 A, B ANTI EGFR ANTIBODY FV REGION VH fragment 9606
350 6EY0 2 E, G, H llama nanobody nb01 9844
351 6EY0 3 F llama nanobody nb01 9844
352 1JHL 2 H IGG1-KAPPA D11.15 FV (HEAVY CHAIN) 10090
353 5F9A 2 C Nanobody Nb-ER19 9844
354 4LLV 1 A, C, E, H 4E10 Fv heavy chain 9606
355 4LAR 1 H Single heavy chain variable fragment Heavy Chain 10090
356 5CBA 1 A, C 3b4 heavy chain 9606
357 5VXJ 2 B, D, F, H, J single-domain antibody JMK-E3 30538
358 1A14 2 H NC10 FV (HEAVY CHAIN) VH DOMAIN OF ANTI-NEURAMINIDASE ANTIBODY NC10 COVALENTLY JOINED BY A FIVE-RESIDUE POLYPEPTIDE LINKER 10090
359 1C08 2 B ANTI-HEN EGG WHITE LYSOZYME ANTIBODY (HYHEL-10) VH FRAGMENT 10090
360 2OTW 2 B, D Fv heavy chain variable domain VH 10090
361 3STB 1 A, B single domain antibody VHH 9844
362 2YSS 2 B ANTI-LYSOZYME ANTIBODY FV REGION VH FRAGMENT 9606
363 4W6W 2 B NbFedF6 9844
364 5JA8 2 B, D, F, H Nanobody 2 9844
365 2YBR 1 A, D, G SINGLE CHAIN ANTIBODY FRAGMENT 9004G HEAVY CHAIN, RESIDUES 1-117 9606
366 2BJM 1 H IGE SPE7 HEAVY CHAIN ANTHRONE ATTACHED HEAVY CHAIN, RESIDUES 1-120 10090
367 1P4B 2 H Antibody Variable heavy chain 10090
368 5U4M 2 B V1C7 VHH antibody 30538
369 5O0W 2 E, F, G, H Nb474 30538
370 4Y5V 1 A, D, G diabody 305 VH domain 9606
371 1DQL 2 H IGM MEZ IMMUNOGLOBULIN HEAVY CHAIN VARIABLE DOMAIN FRAGMENT 9606
372 1JTO 1 A, B Vh Single-Domain Antibody VH domain fragment 9838
373 3V0A 3 C Llama antibody F12 9844
374 5F97 2 E, F, G, H Nanbody Nb-ER19 9844
375 3K80 1 A, B Antibody 9844
376 5VAQ 2 B Nb914 Nanobody 9844
377 1QD0 1 A VHH-R2 ANTI-RR6 ANTIBODY VARIABLE DOMAIN OF A HEAVY CHAIN ANTIBODY 9844
378 5F8Q 2 C, D Nanobody Nb-ER19 9844
379 4U05 1 A, B Single Domain Antibody 9844
380 5F9D 2 C Nanobody Nb-ER19 9844
381 4X4Y 1 A, C Human Variable Heavy Chain of Herceptin 9606
382 4LGP 2 B, D VHH1 camelid nanobody 30538
383 2P48 2 B ANTIBODY CAB-RN05 9838
384 5U4L 2 B V1C7 VHH antibody G29R variant 30538
385 5VXK 1 B single-domain antibody JMK-H2 30538
386 5F7M 2 C, D Nanobody Nb-ER19 9844
387 5NBL 3 E, F nAct-Nanobody N-actin and Arp4 specific nanobody with a C-terminal double Strep-Tag. 30538
388 5DA4 1 A, B, C Nanobody recognizing the membrane protein SLC26Dg 9844
389 5F7W 2 C, D Nanobody Nb-ER19 9844
390 4YQX 1 H, N JES6-1 VH domain 10116
391 1EZV 10 X HEAVY CHAIN (VH) OF FV-FRAGMENT 10090
392 3U6R 1 A, H Antibody 1:7 (Heavy chain) 9606
393 1NMC 2 B, H SINGLE CHAIN ANTIBODY VH AND VL DOMAINS OF ANTI-NEURAMINIDASE ANTIBODY NC10 COVALENTLY JOINED BY A FIFTEEN RESIDUE POLYPEPTIDE LINKER 10090
394 1MEL 1 A, B VH SINGLE-DOMAIN ANTIBODY 9838
395 4NC1 2 C, D A20.1 VHH 9844
396 4NC1 3 E, F A26.8 VHH 9844
397 5M30 2 D, E, F Anti-vesicular stomatitis virus N VHH 30538
398 4WEU 1 D, E Anti-F4+ETEC bacteria VHH variable region 9844
399 2DQF 2 B, E Ig VH,anti-lysozyme 10090
400 5E7F 1 A, B, C nanobody L06 9838
401 2P46 2 B, D ANTIBODY CAB-RN05 9838
402 3CXH 10 J, U HEAVY CHAIN (VH) OF FV-FRAGMENT 10090
403 5YOY 3 G, H, I, P, Q, R Golimumab heavy chain variable region 9606
404 5LWF 2 C, D Camelid heavy-chain antibody variable fragment cAb-G10S 9844
405 5LHP 2 B Camelid-Derived Antibody Fragment 30538
406 5USF 2 C, D Immunoglobulin heavy chain variable region 9844
407 1P84 10 J Heavy Chain (Vh) Of Fv-Fragment 10090
408 5SV4 1 A, B Single Domain Antibody A3C8 9844
409 4LGS 2 B Camelid nanobody (VHH4) 30538
410 3QXV 1 A, B, C, D, E Anti-Methotrexate CDR1-4 Graft VHH 9844
411 5Y80 2 B NANOBODY 9844
412 2XTJ 4 D FAB FROM A HUMAN MONOCLONAL ANTIBODY, 1D05 HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-131 9606
413 5CBE 1 A, C E10 heavy chain 9606
414 2P47 2 B ANTIBODY CAB-RN05 9838
415 4KRM 2 B, D, F, H, J, L Nanobody/VHH domain 7D12 9844
416 3WXW 2 H V region heavy chain 10090
417 3K3Q 1 A llama Aa1 VHH domain 9844
418 4P2C 3 G, H, I, J, K Nanobody 1, Anti-F4+ETEC bacteria VHH variable region 9844
419 1AR1 3 C ANTIBODY FV FRAGMENT 10090
420 3EZJ 2 B, D, F, H NANOBODY NBGSPD_7 9844
421 5VNW 2 C, D Nb.b201 32630
422 1BVK 2 B, E HULYS11 FV 9606
423 6FE4 2 F, G, H, I, J Nb113 30538
424 5NML 1 A, B, C, D, E, F, G, H, I, J Nanobody Nb36 Ser85Cys 9844
425 2CJU 1 H NQ16-113.8 ANTI-PHOX ANTIBODY 10090
426 5HVF 2 B VHH-i83 30538
427 1P4I 2 H antibody variable heavy chain 10090
428 4PGJ 1 A, C Human heavy chain domain antibody 9606
429 4KDT 1 A, B Nanobody24 9835
430 6H02 2 B LAMA nanobody NB106 Lama nanobody generated against Human Mediator subunit MED23 9844
431 3CFI 3 C, F, I, L Nanobody NBEPSIJ_11 9844
432 2VH5 1 H ANTI-RAS FV HEAVY CHAIN 9606
433 4S10 1 A, B GELSOLIN NANOBODY GELSOLIN NANOBODY 9844
434 5MJE 2 B Nanobody 8 9844
435 3LH2 2 H, I, J, K Fv 4E10 heavy chain 9606
436 3OGO 2 E, F, G, H GFP-nanobody 9838
437 4C59 2 B NANOBODY 9844
438 5VXL 2 B single-domain antibody JPS-G3 30538
439 1OAZ 2 H, J IMMUNOGLOBULIN E FV REGION, RESIDUES 1-122 10090
440 6H7N 3 C, D Camelid antibody fragment Nb6B9 9844
441 4DK6 1 A, B single domain antibody VHH 9844
442 5F93 2 C, D, F, H Nanobody Nb-ER19 9844
443 5F7L 2 B, D Nanobody Nb-ER14 9844
444 1OAY 1 H, J IMMUNOGLOBULIN E FV REGION, RESIDUES 1-122 10090
445 5HVG 2 B, D VHH-a204 30538
446 4LAQ 1 H Single heavy chain variable fragment Heavy chain 10090
447 3UPC 1 A, B, C, D, E, F, G, H, I, J heavy chain variable domain 9606
448 4W2Q 1 A, C, E, G Anti-Marburgvirus Nucleoprotein Single Domain Antibody C 9844
449 5HVH 2 B VHH-a204 30538
450 5HVH 3 C VHH-i83 30538
451 4XT1 3 C nanobody 7 30538
452 5LXG 2 H V REGION HEAVY CHAIN 10090
453 5HM1 1 A, B, C lama VHH antibody 2E7 9844
454 5NBM 3 E, F nAct-Nanobody N-actin and Arp4 binding nanobody with a C-terminal double Strep-Tag. 30538
455 5FUC 3 E, V VHH6 9838
456 4RZC 1 A, C, E, H Fv M6P-1 light chain 9986
457 3H3P 1 H, I Fv 4E10 heavy chain 9606
458 5O2U 2 B, D VHH 59H10 9844
459 5SV3 1 A, C Anti-Ricin A-chain Single Domain Antibody (sdAb) A3C8 9844
460 3NN8 1 A, C, D, G Engineered scFv, heavy chain 10090
461 5OMN 2 C Nanobody (VHH) Nano-27 30538
462 4KRP 2 B Nanobody/VHH domain 9G8 9844
463 1OAX 1 H, J IMMUNOGLOBULIN E FV REGION, RESIDUES 1-122 10090
464 6FUZ 2 N nanobody 9844
465 4FHB 2 D Nb179 9844
466 4DK3 1 A, B single domain antibody VHH 9844
467 4KRL 1 B Nanobody/VHH domain 7D12 9844
468 4V1D 1 A SINGLE CHAIN ANTIBODY FRAGMENT LR, HEAVY CHAIN 9606
469 4V1D 4 D SINGLE CHAIN ANTIBODY FRAGMENT RU1, HEAVY CHAIN 9606
470 1BZQ 2 K, L, M, N PROTEIN (ANTIBODY CAB-RN05) VARIABLE DOMAIN 9838
471 1NMA 3 H FAB NC10 RESOLUTION OF 3.0 ANGSTROMS 10090
472 1YZZ 1 A, B anti-VSG immunoglobulin heavy chain variable domain cAbAn33 9838
473 4LDE 2 B Camelid Antibody Fragment 9844
474 4Y5Y 1 A, D diabody 330 VH domain 9606
475 5DMJ 2 B, E, G 3H65-5 domain antibody (dAb) 9606
476 1BVL 1 A, C HULYS11 FV 10090
477 6H7L 3 C, D Camelid antibody fragment Nb6B9 9844
478 3RJQ 2 B Llama VHH A12 9844
479 1ZMY 1 A Antibody cabbcII-10:lys3 N-terminus, 142 residues 9838
480 6H7K 3 C, D Camelid antibody fragment Nb80 9844
481 6CF2 1 A Anti-Rev Antibody, heavy chain Fab single-chain variable fragment 9986
482 3AB0 2 B, E antibody ScFv fragment, heavy chain 10090
483 3LHP 1 H, I Fv 4E10 heavy chain 9606
484 5Y7Z 2 C, D NANOBODY 9844
485 4N1H 2 B, D Camelid heavy-chain antibody variable fragment cAb-F11N 9844
486 6CK9 2 D 35O22 scFv heavy chain portion 9606
487 6EQI 2 B Nb696 9844
488 2BSE 2 D, E, F LLAMA IMMUNOGLOBULIN VHH RECOGNITION DOMAIN, RESIDUES 1-123 9844
489 1YC8 1 A, B anti-VSG immunoglobulin heavy chain variable domain cAbAn33 cAbAn33-hu 9838
490 4KFZ 2 C, D Anti-LMO2 VH 9606
491 2UUD 1 H, J NQ10-1.12 ANTI-PHOX ANTIBODY 10090
492 5TOJ 2 D, E, F Single-domain antibody F-VHH-4 9844
493 6H7O 3 C, D Camelid antibody fragment Nb6B9 9844
494 4Y5X 1 A, D, G, J diabody 310 VL domain 9606
495 4YGA 2 B, D, F, H VHH-1B7 30538
496 4UT9 2 H, I, J, K BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C10 SCFV, HEAVY CHAIN DOMAIN 9606
497 2A9N 2 H, I fluorescein-scfv heavy chain 9606
498 5GS0 3 D, F heavy chain (anti-TLR3) 10090
499 5GS0 4 H, X heavy chain (anti-Lid) 10090
500 5YY5 2 H Heavy chain 9606
501 5YY5 4 C Heavy chain 9606
502 5G5X 2 B NANOBODY NB330, SELECTED FROM LLAMA, C-TERMINAL 6XHIS- TAG 9844
503 1KYO 10 J, U HEAVY CHAIN (VH) OF FV-FRAGMENT RESIDUES 1-127 10090
504 5GRJ 1 H avelumab H chain 9606
505 4NKD 1 A, C, E, G Engineered scFv heavy chain 10090
506 5BOZ 2 G, H, I, J, K, L VHH single chain antibody E1 30538
507 4KRO 2 B Nanobody/VHH domain EgA1 9844
508 3WXV 2 H V region heavy chain 10090
509 4KV5 2 E, G, H, J heavy chain GC1009 scFv 9606
510 3DWT 1 A, B, C, D, E, F, G, H cAbBCII-10 9838
511 5TJW 2 K NP-specific inhibitory VHH 30538
512 1QLE 5 H HEAVY CHAIN ANTIBODY FV FRAGMENT 10090
513 6H7M 3 C, D Camelid antibody fragment Nb6B9 562
514 4LDL 2 B Camelid Antibody Fragment 9844
515 4LDO 2 B Camelid Antibody Fragment 9844
516 5XJ3 1 A, D, G, J ipilimumab-VH 9606
517 3SN6 5 N Camelid antibody VHH fragment 9844
518 5M94 2 B, D CAMELID ANTIBODY FRAGMENT, NANOBODY 9844
519 4M8Q 1 A, H GEP1 Fv heavy chain 9606
520 5NHR 2 A, H Bimagrumab Fv heavy-chain VH 9606
521 4W2O 1 A, C, E, G Anti-Marburgvirus Nucleoprotein Single Domain Antibody B 9844
522 5O8F 2 K, O Nanobody Nb25 9844
523 5O8F 3 L, M, N Nanobody Nb25 9844
524 5NQW 2 C, D 026 9844
525 5C3L 4 D Nanobody Nb15 Nanobody 9838
526 5J3H 2 C mAb 83-7 Fab heavy chain 10090
527 5U8R 2 H Fv 24-60 heavy chain Heavy chain variable domain (residues 1-118) of mAb 24-60, including additional Gly-Thr at the N terminus and Glu-Asn-Leu-Tyr-Phe-Gln at C terminus. 10090
528 1G6V 2 K ANTIBODY HEAVY CHAIN CAB-CA05, VARIABLE DOMAIN 9838
529 5UK4 2 a, b, c, d, e, f, g, h, i, j, k, l, m, n, o, p, q, r, s, t Anti-vesicular stomatitis virus N VHH GGLPETGGHHHHHH Sortase A recognition mofiv and HIS TAG 30538
530 5FV2 1 A, B, C VH DOMAIN ANTIBODY VH DOMAIN ANTIBODY 9606
531 4WGV 2 B, D Camelid antibody fragment, nanobody 9844
532 6H7J 3 C, D Camelid antibody fragment Nb80 9844
533 5OJM 2 K, L, M, N, O Nanobody Nb25 9844
534 6B73 2 C, D Nanobody 9844
535 4PIR 2 F, G, H, I, J VHH15 9844
536 5XWD 2 H VH chain of 059-152 9606
537 6C5W 2 C, E nanobody 32644
538 4QKX 2 B R9 protein 9844
539 5JQH 2 C, D Nanobody60, Nb60 9844
540 4YBQ 3 D, F antibody Fv fragment heavy chain 10090
541 4PD4 10 J Igh protein 10090
542 6C9W 2 B Nanobody9047 Full 9844
543 5DA0 2 B Nanobody 9844
544 4R0L 1 A, H Antibody 1C6 Heavy chain 10090
545 5U8Q 3 H Fv 24-60 heavy chain Heavy chain variable domain (residues 1-118) of mAb 24-60, including additional Gly-Thr at the N terminus and Glu-Asn-Leu-Tyr-Phe-Gln at C terminus. 10090
546 3P0G 2 B Camelid Antibody Fragment NANOBODY 9844
547 4ODX 2 A, H GEP7 Fv heavy chain 9606
548 5M95 2 B, D CAMELID ANTIBODY FRAGMENT, NANOBODY 9844
549 4WGW 2 B, D Camelid antibody fragment, nanobody 9844
550 1RVF 6 H FAB 17-IA 10090
551 5JZ7 2 C, G, H, J MEDI578 scFv, heavy chain 9606
552 5IHL 2 B, E, G, I 3H56-5 domain antibody (dAb) 3H56-5 dAb 9606
553 4MQS 2 B Nanobody 9-8 9844
554 5DHY 1 A, H Anti-Rev Antibody Fab single-chain variable fragment, heavy chain 9986
555 5WB2 3 D nanobody B1 32630
556 1QFW 4 H ANTIBODY (ANTI ALPHA SUBUNIT) (HEAVY CHAIN) FV 10090
557 1QFW 6 I ANTIBODY (ANTI BETA SUBUNIT) (HEAVY CHAIN) FV 10090
558 3K81 2 A, B Single strand antibody VHH domain single domain antibody VHH 9844
559 4OGA 3 C monoclonal antibody fab 83-7 fragment - heavy chain 10090
560 4MQT 2 B Nanobody 9-8 9844
561 5TOK 2 D, E, F Single-domain antibody F-VHH-L66 9844
562 4NKM 1 A, C, E, G Engineered scFv heavy chain 10090
563 3W11 3 C monoclonal antibody fab 83-7 fragment - heavy chain 10090
564 4NKO 2 B, D, F Engineered scFv heavy chain 10090
565 5EUL 4 V AYC08 30538
566 5GXB 2 B nanobody 30538
567 5NBD 2 C Nanobody 9844
568 3W13 2 C monoclonal antibody fab 83-7 fragment - heavy chain 10090
569 3W12 2 C monoclonal antibody fab 83-7 fragment - heavy chain 10090
570 5H8O 1 A VHH nanobody 9844
571 4KSD 2 B R2 protein 9844
572 5DHZ 1 H Anti-Rev Antibody Fab single-chain variable fragment, heavy chain 9986
573 2A0L 3 D, F 33H1 Fv fragment Fv fragment, heavy chain 10090
574 5DFZ 4 E Nanobody binding S. cerevisiae Vps34 9844
575 5UKB 1 a, b, c, d, e Anti-vesicular stomatitis virus N VHH GGLPETGGHHHHHH Sortase A recognition motif and HIS tag. 30538
576 5WDU 2 D, O, W bnAb NIH45-46 scFv heavy chain 9606
577 5TD8 5 E nanobody 30538
578 6MF7 2 H antibody 860-55D heavy chain Fab 9606
579 6E3Y 2 N Nanobody 35 9844
580 6A96 1 K, L, O Nb25 9844
581 6DZL 4 G, H, I Fv domain of ADI-15878 Fab heavy chain 9606
582 6DZM 4 G, I, J Antibody ADI-15878 Fab, heavy chain 9606
583 6CUE 3 3, H, h vFP7.04 Heavy chain 10090
584 6CUE 5 5, M, m PGT122 heavy Chain 9606
585 6CUE 7 7, Q, q VRC03 Heavy chain 9606
586 6CUF 3 5, M, m PGT122 Heavy chain 9606
587 6CUF 6 8, Q, q VRC03 heavy chain 9606
588 6CDI 4 5, M, m PGT122 Heavy Chain 9606
589 6BSP 1 A U4 Heavy chain 10090
590 6B3J 6 N Nanobody 35 9844
591 6EHG 3 C hC3Nb1 9844
592 5Y0A 2 D, F, H variable region of Fab ZKA190 heavy chain 9606
593 5XS7 2 H Heavy chain of Fab 1D5 10090
594 5W3L 5 E C5 antibody variable heavy domain 10090
595 5W3M 1 E C5 antibody variable heavy domain 10090
596 5W3O 1 D C5 antibody variable heavy domain 10090
597 5W3E 1 E C5 antibody variable heavy domain 10090
598 5VAI 6 N nanobody 35 9844
599 5UZ7 4 N NANOBODY 35 9844
600 5TSJ 10 1, 2 Human heavy chain domain antibody 9606
601 5TR1 2 H, I Monoclonal antibody, Fab fragment, heavy chain 10090
602 5TQQ 3 H, I Monoclonal antibody, Fab fragment, heavy chain 10090
603 5H32 2 G, I, K C10 IgG heavy chain variable region 9606
604 5H37 3 G, I, K C10 IgG heavy chain variable region 9606
605 5H30 3 G, I, K IgG C10 heavy chain 9606
606 5KWL 4 7 VHH 10E 9838
607 5KTZ 4 7 VHH 12B 9838
608 5KU0 4 7 VHH 17B 9838
609 5KU2 4 7 VHH 7A 9838
610 5KEL 3 H, P, Q c2G4 variable Fab domain heavy chain 9606
611 5KEL 5 C, J, M c13C6 variable Fab domain heavy chain 9606
612 5KEM 2 B, G BDBV91 variable Fab domain heavy chain 9606
613 5KEM 3 D, I c13C6 variable Fab domain heavy chain 9606
614 5KEN 3 C, G, N c4G7 variable Fab domain heavy chain 9606
615 5KEN 6 J, Q c13C6 variable Fab domain heavy chain 9606
616 3JCX 2 H Fab E heavy chain 10116
617 5FOJ 1 A NANOBODY 9838
618 3JBC 5 7 nanobody VHH PVSP29F 9838
619 3JBD 5 7 nanobody VHH PVSP6A 9838
620 3JBE 5 7 nanobody VHH PVSS8A 9838
621 3JBF 5 7 nanobody VHH PVSP19B 9838
622 3JBG 5 7 nanobody VHH PVSS21E 9838
623 3JBA 2 H H16.U4 antibody heavy chain Fab variable domain 10090
624 3JAU 2 H Heavy chain of Fab fragment variable region of antibody D5 10090
625 5A1Z 3 G, I, K ANTIGEN-BINDING FRAGMENT OF HUMAN ANTIBODY 2D22 - HEAVY CHAIN 180 COPIES OF FAB 2D22 MOLECULE BIND TO VIRUS SURFACE 9606
626 4UIF 3 G, I, K ANTIGEN-BINDING FRAGMENT OF HUMAN ANTIBODY 2D22 - HEAVY CHAIN 9606
627 4UIH 2 D, F ANTIGEN-BINDING FRAGMENT OF HUMAN ANTIBODY 2D22 -HEAVY CHAIN 9606
628 4UDF 4 11, 15, 19, 1D, 1H, 1L, 1P, 1T, 1X, 21, 25, 29, 2D, 2H, 2L, 2P, 2T, 2X, 31, 35, 39, 3D, 3H, 3L, 3P, 3T, 3X, 41, 45, 49, 4D, 4H, 4L, 4P, 4T, 4X, 51, 55, 59, 5D, 5H, 5L, 5P, 5T, 5X, 61, 65, 69, 6D, 6H, 6L, 6P, 6T, 6X, 7D, 7H, 7L, 7P, 7T, 7X HUMAN MONOCLONAL ANTIBODY 9606
629 3J8Z 3 F, G, H, I H16.1A heavy chain variable domain Fab 10090
630 3J8V 3 F, G, H, I H16.14J heavy chain variable domain Fab 10090
631 3J8W 2 F, G, H, I H263.A2 heavy chain variable domain Fab 10090
632 3J7E 2 B, D, F, H H16.V5 Fab heavy chain variable domain 10090
633 3J6U 3 H Fab 5J7 heavy chain variable region 9606
634 4CKD 2 H, I, J, K SCFV13R4 ANTIBODY FV HEAVY CHAIN 10090
635 3IY1 2 B Fab B, heavy chain 10116
636 3IY2 2 B Antibody 6, heavy chain FRAGMENT OF ANTIBODY 6 10090
637 3IY3 2 B antibody fragment from neutralizing antibody 8 (heavy chain) 10090
638 3IY4 2 B fragment of neutralizing antibody 15 (heavy chain) 10090
639 3IY5 2 B antibody fragment IGG2A (heavy chain) 10090
640 3IY6 2 B fragment from neutralizing antibody E (heavy chain) 10116
641 3IY7 2 B fragment from neutralizing antibody F (heavy chain) 10116
642 3IY0 2 H Fab 14, heavy domain 10090
643 1IEH 1 A BRUC.D4.4 SINGLE DOMAIN ANTIBODY FROM A NAIVE LLAMA LIBRARY 9844
644 1G9E 1 A H14 9844
645 1QNZ 1 H 0.5B ANTIBODY (HEAVY CHAIN) FV 10090
646 1VHP 1 A VH-P8 9606